Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-02

Clinical Trial Update: Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms

View source ↗

Summary

Imperial College London is conducting a study to evaluate volatile organic compounds in breath as biomarkers for esophageal cancers. The trial is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Imperial College London | Conditions: Oesophageal Squamous Cell Carcinoma, Oesophageal Cancer | Status: RECRUITING